1091 related articles for article (PubMed ID: 29743249)
1. Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.
De Francesco EM; Sotgia F; Lisanti MP
Biochem J; 2018 May; 475(9):1611-1634. PubMed ID: 29743249
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cell metabolism: target for cancer therapy.
Chae YC; Kim JH
BMB Rep; 2018 Jul; 51(7):319-326. PubMed ID: 29764565
[TBL] [Abstract][Full Text] [Related]
3. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
Yadav AK; Desai NS
Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
[TBL] [Abstract][Full Text] [Related]
4. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
Eun K; Ham SW; Kim H
BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming of central carbon metabolism in cancer stem cells.
Wong TL; Che N; Ma S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1728-1738. PubMed ID: 28502706
[TBL] [Abstract][Full Text] [Related]
7. Potential Therapies Targeting Metabolic Pathways in Cancer Stem Cells.
Shen YA; Chen CC; Chen BJ; Wu YT; Juan JR; Chen LY; Teng YC; Wei YH
Cells; 2021 Jul; 10(7):. PubMed ID: 34359941
[TBL] [Abstract][Full Text] [Related]
8. Cancer cells stemness: A doorstep to targeted therapy.
Prasad S; Ramachandran S; Gupta N; Kaushik I; Srivastava SK
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165424. PubMed ID: 30818002
[TBL] [Abstract][Full Text] [Related]
9. Drug Resistance Driven by Cancer Stem Cells and Their Niche.
Prieto-Vila M; Takahashi RU; Usuba W; Kohama I; Ochiya T
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194401
[TBL] [Abstract][Full Text] [Related]
10. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
[TBL] [Abstract][Full Text] [Related]
11. Metabolic features of cancer stem cells: the emerging role of lipid metabolism.
Mancini R; Noto A; Pisanu ME; De Vitis C; Maugeri-Saccà M; Ciliberto G
Oncogene; 2018 May; 37(18):2367-2378. PubMed ID: 29445137
[TBL] [Abstract][Full Text] [Related]
12. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
Safa AR
Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
[TBL] [Abstract][Full Text] [Related]
13. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
14. Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications.
Marzagalli M; Raimondi M; Fontana F; Montagnani Marelli M; Moretti RM; Limonta P
Semin Cancer Biol; 2019 Dec; 59():221-235. PubMed ID: 31265892
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance.
Najafi M; Farhood B; Mortezaee K; Kharazinejad E; Majidpoor J; Ahadi R
J Cancer Res Clin Oncol; 2020 Jan; 146(1):19-31. PubMed ID: 31734836
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic Metabolism Acts as a Prerequisite Step for Induction of Cancer Metastasis and Cancer Stem Cell Phenotype.
Lee SY; Ju MK; Jeon HM; Lee YJ; Kim CH; Park HG; Han SI; Kang HS
Oxid Med Cell Longev; 2018; 2018():1027453. PubMed ID: 30671168
[TBL] [Abstract][Full Text] [Related]
17. Cancer Stem Cells: Basic Concepts and Therapeutic Implications.
Nassar D; Blanpain C
Annu Rev Pathol; 2016 May; 11():47-76. PubMed ID: 27193450
[TBL] [Abstract][Full Text] [Related]
18. Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine).
De Francesco EM; Ózsvári B; Sotgia F; Lisanti MP
Front Oncol; 2019; 9():615. PubMed ID: 31440463
[TBL] [Abstract][Full Text] [Related]
19. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways.
Kahlert UD; Mooney SM; Natsumeda M; Steiger HJ; Maciaczyk J
Int J Cancer; 2017 Jan; 140(1):10-22. PubMed ID: 27389307
[TBL] [Abstract][Full Text] [Related]
20. Approaches for targeting cancer stem cells drug resistance.
Rosa R; D'Amato V; De Placido S; Bianco R
Expert Opin Drug Discov; 2016 Dec; 11(12):1201-1212. PubMed ID: 27700193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
